In this study, we show that down-regulation of ROR2 significantly inhibits breast cancer cell proliferation in vitro, and BC tumor growth in vivo, and that the mechanism involves the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. The gene discussed is AKT1; the disease is breast carcinoma.